Injective (INJ) is currently trading at $2.85, reflecting a 24-hour change of 1.38%. The daily range has been relatively narrow, with a high of $2.88 and a low of $2.78, indicating low volatility in the short term.

Trading volume stands at approximately $36.45 million, representing 12.79% of its market cap. This level of volume suggests active trading but not excessive speculation, which is critical for price stability.

The hourly moving averages are mixed, with the 8 SMA at $2.81 showing a positive trend of +1.35%, while the longer-term 144 SMA at $2.97 indicates a downtrend of -4.15%. The convergence of short-term and long-term SMAs highlights a potential consolidation phase, where traders are indecisive about the next price movement.

The RSI readings show that the 1-hour RSI is at 47, suggesting a neutral stance, while the 7-day RSI at 45 indicates slight bearish momentum. The recent price changes over the last 7, 14, and 30 days are all negative, with declines of -6.55%, -15.67%, and -12.73%, respectively, confirming a bearish trend over these periods.

Considering the recent price movements, technical indicators, and overall market sentiment, INJ appears to be in a corrective phase after recent highs. The proximity to the recent daily low and negative RSI trends suggest further downside risks before a potential recovery.

Based on this analysis, a Hold rating is recommended. This stance allows investors to monitor for signs of stabilization and potential reversal while avoiding further losses in a currently bearish environment.